Skip to main content
Erschienen in: The Patient - Patient-Centered Outcomes Research 2/2017

01.04.2017 | Systematic Review

The Patient Experience with Soft Tissue Sarcoma: A Systematic Review of the Literature

verfasst von: Randall Winnette, Lisa M. Hess, Steven J. Nicol, Datchen Fritz Tai, Catherine Copley-Merriman

Erschienen in: The Patient - Patient-Centered Outcomes Research | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Soft tissue sarcomas (STS) are a heterogenous group of rare tumors that involve the connective tissue in the body (e.g. muscle, tendons). As with many rare tumors, little is known about the impact of STS on patient well-being.

Objective

The aim of this review was to better understand current knowledge related to patient experience and quality of life (QOL) following diagnosis of STS.

Methods

A systematic review of English-language articles published from 2005 to 2015 was conducted in the PubMed/MEDLINE, Embase, PsychINFO, and Evidence-Based Medicine databases. The review included recent conference proceedings and advocacy websites. Articles were eligible if they included adult STS patient-reported outcomes (PROs) or details on patient experience.

Results

Overall, 3430 articles were identified and 20 were eligible for inclusion. Of these, 14 were clinical studies that included PRO measures, 1 summarized PRO measures used in STS studies, and 5 described the STS patient experience. Patients with STS report a range of impacts on QOL, including emotional well-being, body image, functional deficit following surgery, and practical considerations such as child care and work.

Conclusions

Few studies have published either qualitative or quantitative data on the patient experience with STS. While STS has a measurable impact on QOL, there is a lack of detailed information in the published literature. Although PROs are used in clinical studies of STS, they are not STS-specific and may not capture the unique needs of this population. There is a need for qualitative research to better understand both patient and caregiver experiences in STS.
Literatur
1.
Zurück zum Zitat Kluetz PG, Slagle A, Papadopoulos E, Johnson LL, Donoghue M, Kwitkowski VE, et al. Focusing on core patient-reported outcomes in cancer clinical trials:symptomatic adverse events, physical function, and disease-related symptoms. Clin Cancer Res. 2016;22:1553–8.CrossRefPubMed Kluetz PG, Slagle A, Papadopoulos E, Johnson LL, Donoghue M, Kwitkowski VE, et al. Focusing on core patient-reported outcomes in cancer clinical trials:symptomatic adverse events, physical function, and disease-related symptoms. Clin Cancer Res. 2016;22:1553–8.CrossRefPubMed
2.
Zurück zum Zitat Corbin J, Strauss A. Basics of qualitative research. Techniques and procedures for developing grounded theory. Thousand Oaks: Sage Publications; 2015. Corbin J, Strauss A. Basics of qualitative research. Techniques and procedures for developing grounded theory. Thousand Oaks: Sage Publications; 2015.
3.
Zurück zum Zitat Brod M, Tesler LE, Christensen TL. Qualitative research and content validity: developing best practices based on science and experience. Qual Life Res. 2009;18:1263.CrossRefPubMed Brod M, Tesler LE, Christensen TL. Qualitative research and content validity: developing best practices based on science and experience. Qual Life Res. 2009;18:1263.CrossRefPubMed
4.
Zurück zum Zitat LaVela SL, Gallan AS. Evaluation and measurement of patient experience. Patient Exp J. 2014;1(1):28–36. LaVela SL, Gallan AS. Evaluation and measurement of patient experience. Patient Exp J. 2014;1(1):28–36.
5.
Zurück zum Zitat Hareendran A, Gnanasakthy A, Winnette R, Revicki D. Capturing patients’ perspectives of treatment in clinical trials/drug development. Contemp Clin Trials. 2012;33(1):23–8.CrossRefPubMed Hareendran A, Gnanasakthy A, Winnette R, Revicki D. Capturing patients’ perspectives of treatment in clinical trials/drug development. Contemp Clin Trials. 2012;33(1):23–8.CrossRefPubMed
6.
Zurück zum Zitat Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-analyses: the PRISMA statement. PLoS Med. 2009;6(6):e1000097.CrossRefPubMedPubMedCentral Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-analyses: the PRISMA statement. PLoS Med. 2009;6(6):e1000097.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Gundle KR, Cizik AM, Jones RL, Davidson DJ. Quality of life measures in soft tissue sarcoma. Expert Rev Anticancer Ther. 2015;15:95–100.CrossRefPubMed Gundle KR, Cizik AM, Jones RL, Davidson DJ. Quality of life measures in soft tissue sarcoma. Expert Rev Anticancer Ther. 2015;15:95–100.CrossRefPubMed
8.
Zurück zum Zitat Peiper M, Matthaei H, Bolke E, Zurakowski D, Orth K, Heinecke A, et al. Compartmental resection for subfascial extremity soft tissue sarcoma and quality of life in long-term survivors. Wien Klin Wochenschr. 2011;123:488–95.CrossRefPubMed Peiper M, Matthaei H, Bolke E, Zurakowski D, Orth K, Heinecke A, et al. Compartmental resection for subfascial extremity soft tissue sarcoma and quality of life in long-term survivors. Wien Klin Wochenschr. 2011;123:488–95.CrossRefPubMed
9.
Zurück zum Zitat Poveda A, Lopez-Pousa A, Martin J, Garcia Del Muro J, Bernabe R, Casado A, et al. Phase II clinical trial with pegylated liposomal doxorubicin (CAELYX®/Doxil®) and quality of life evaluation (EORTC QLQ-C30) in adult patients with advanced soft tissue sarcomas: a study of the Spanish Group for Research in Sarcomas (GEIS). Sarcoma. 2005;9:127–32.CrossRefPubMedPubMedCentral Poveda A, Lopez-Pousa A, Martin J, Garcia Del Muro J, Bernabe R, Casado A, et al. Phase II clinical trial with pegylated liposomal doxorubicin (CAELYX®/Doxil®) and quality of life evaluation (EORTC QLQ-C30) in adult patients with advanced soft tissue sarcomas: a study of the Spanish Group for Research in Sarcomas (GEIS). Sarcoma. 2005;9:127–32.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Reichardt P, Leahy M, Garcia Del Muro X, Ferrari S, Martin J, Gelderblom H, et al. Quality of life and utility in patients with metastatic soft tissue and bone sarcoma: the Sarcoma Treatment and Burden of Illness in North America and Europe (SABINE) study. Sarcoma. 2012;2012:740279.CrossRefPubMedPubMedCentral Reichardt P, Leahy M, Garcia Del Muro X, Ferrari S, Martin J, Gelderblom H, et al. Quality of life and utility in patients with metastatic soft tissue and bone sarcoma: the Sarcoma Treatment and Burden of Illness in North America and Europe (SABINE) study. Sarcoma. 2012;2012:740279.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat No authors listed. Pazopanib and soft-tissue sarcomas. Too toxic. Prescrire Int. 2013;22:145–7. No authors listed. Pazopanib and soft-tissue sarcomas. Too toxic. Prescrire Int. 2013;22:145–7.
13.
Zurück zum Zitat Ostacoli L, Saini A, Zuffranieri M, Boglione A, Carletto S, De Marco I, et al. Quality of life, anxiety and depression in soft tissue sarcomas as compared to more common tumours: an observational study. Appl Res Qual Life. 2014;9:123–31.CrossRef Ostacoli L, Saini A, Zuffranieri M, Boglione A, Carletto S, De Marco I, et al. Quality of life, anxiety and depression in soft tissue sarcomas as compared to more common tumours: an observational study. Appl Res Qual Life. 2014;9:123–31.CrossRef
14.
Zurück zum Zitat Granda-Cameron C, Hanlon AL, Lynch MP, Houldin A. Experience of newly diagnosed patients with sarcoma receiving chemotherapy. Oncol Nurs Forum. 2011;38:160–9.CrossRefPubMed Granda-Cameron C, Hanlon AL, Lynch MP, Houldin A. Experience of newly diagnosed patients with sarcoma receiving chemotherapy. Oncol Nurs Forum. 2011;38:160–9.CrossRefPubMed
15.
Zurück zum Zitat Davidge K, Bell R, Ferguson P, Turcotte R, Wunder J, Davis AM. Patient expectations for surgical outcome in extremity soft tissue sarcoma. J Surg Oncol. 2009;100:375–81.CrossRefPubMed Davidge K, Bell R, Ferguson P, Turcotte R, Wunder J, Davis AM. Patient expectations for surgical outcome in extremity soft tissue sarcoma. J Surg Oncol. 2009;100:375–81.CrossRefPubMed
16.
Zurück zum Zitat Davidge KM, Wunder J, Tomlinson G, Wong R, Lipa J, Davis AM. Function and health status outcomes following soft tissue reconstruction for limb preservation in extremity soft tissue sarcoma. Ann Surg Oncol. 2010;17:1052–62.CrossRefPubMed Davidge KM, Wunder J, Tomlinson G, Wong R, Lipa J, Davis AM. Function and health status outcomes following soft tissue reconstruction for limb preservation in extremity soft tissue sarcoma. Ann Surg Oncol. 2010;17:1052–62.CrossRefPubMed
17.
Zurück zum Zitat Leahy M, Reichardt P, Garcia Del Muro X, Pisters P, Chawla S, Martin J, et al. Health-related quality of life in patients with metastatic sarcoma—the sarcoma treatment and burden of illness study in North America and Europe (Sabine) study. Ann Oncol. 2010;21:viii414–5. Leahy M, Reichardt P, Garcia Del Muro X, Pisters P, Chawla S, Martin J, et al. Health-related quality of life in patients with metastatic sarcoma—the sarcoma treatment and burden of illness study in North America and Europe (Sabine) study. Ann Oncol. 2010;21:viii414–5.
18.
Zurück zum Zitat Schreiber D, Bell RS, Wunder JS, O’Sullivan B, Turcotte R, Masri BA, et al. Evaluating function and health related quality of life in patients treated for extremity soft tissue sarcoma. Qual Life Res. 2006;15:1439–46.CrossRefPubMed Schreiber D, Bell RS, Wunder JS, O’Sullivan B, Turcotte R, Masri BA, et al. Evaluating function and health related quality of life in patients treated for extremity soft tissue sarcoma. Qual Life Res. 2006;15:1439–46.CrossRefPubMed
19.
Zurück zum Zitat Shingler SL, Swinburn P, Lloyd A, Diaz J, Isbell R, Manson S, et al. Elicitation of health state utilities in soft tissue sarcoma. Qual Life Res. 2013;22:1697–706.CrossRefPubMed Shingler SL, Swinburn P, Lloyd A, Diaz J, Isbell R, Manson S, et al. Elicitation of health state utilities in soft tissue sarcoma. Qual Life Res. 2013;22:1697–706.CrossRefPubMed
21.
Zurück zum Zitat Tobias K, Gillis T. Rehabilitation of the sarcoma patient-enhancing the recovery and functioning of patients undergoing management for extremity soft tissue sarcomas. J Surg Oncol. 2015;111:615–21.CrossRefPubMed Tobias K, Gillis T. Rehabilitation of the sarcoma patient-enhancing the recovery and functioning of patients undergoing management for extremity soft tissue sarcomas. J Surg Oncol. 2015;111:615–21.CrossRefPubMed
23.
Zurück zum Zitat Magne N, Pacaut C, Auberdiac P, Jacquin JP, Chargari C, Chauleur C, et al. Sarcoma of vulva, vagina and ovary. Best Pract Res Clin Obstet Gynaecol. 2011;25:797–801.CrossRefPubMed Magne N, Pacaut C, Auberdiac P, Jacquin JP, Chargari C, Chauleur C, et al. Sarcoma of vulva, vagina and ovary. Best Pract Res Clin Obstet Gynaecol. 2011;25:797–801.CrossRefPubMed
24.
Zurück zum Zitat Barr RD, Wunder JS. Bone and soft tissue sarcomas are often curable—but at what cost? A call to arms (and legs). Cancer. 2009;115:4046–54.CrossRefPubMed Barr RD, Wunder JS. Bone and soft tissue sarcomas are often curable—but at what cost? A call to arms (and legs). Cancer. 2009;115:4046–54.CrossRefPubMed
25.
Zurück zum Zitat Parsons JA, Davis AM. Rehabilitation and quality of life issues in patients with extremity soft tissue sarcoma. Curr Treat Options Oncol. 2004;5:477–88.CrossRefPubMed Parsons JA, Davis AM. Rehabilitation and quality of life issues in patients with extremity soft tissue sarcoma. Curr Treat Options Oncol. 2004;5:477–88.CrossRefPubMed
26.
Zurück zum Zitat Gough NJ, Smith C, Ross JR, Riley J, Judson I. Symptom burden, survival and palliative care in advanced soft tissue sarcoma. Sarcoma. 2011;2011:325189.CrossRefPubMedPubMedCentral Gough NJ, Smith C, Ross JR, Riley J, Judson I. Symptom burden, survival and palliative care in advanced soft tissue sarcoma. Sarcoma. 2011;2011:325189.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Fuchs J, Dantonello TM, Blumenstock G, Kosztyla D, Klingebiel T, Leuschner I, et al. Treatment and outcome of patients suffering from perineal/perianal rhabdomyosarcoma: results from the CWS trials—retrospective clinical study. Ann Surg. 2014;259:1166–72.CrossRefPubMed Fuchs J, Dantonello TM, Blumenstock G, Kosztyla D, Klingebiel T, Leuschner I, et al. Treatment and outcome of patients suffering from perineal/perianal rhabdomyosarcoma: results from the CWS trials—retrospective clinical study. Ann Surg. 2014;259:1166–72.CrossRefPubMed
29.
Zurück zum Zitat Gough N, Ross J, Koffman J, Riley J, Judson I. Symptom burden and oncologist prognostication in advanced soft tissue sarcoma. Palliative Med. 2014;28:656–2014. Gough N, Ross J, Koffman J, Riley J, Judson I. Symptom burden and oncologist prognostication in advanced soft tissue sarcoma. Palliative Med. 2014;28:656–2014.
30.
Zurück zum Zitat Thijssens KM, Hoekstra-Weebers JE, van Ginkel RJ, Hoekstra HJ. Quality of life after hyperthermic isolated limb perfusion for locally advanced extremity soft tissue sarcoma. Ann Surg Oncol. 2006;13:864–71.CrossRefPubMed Thijssens KM, Hoekstra-Weebers JE, van Ginkel RJ, Hoekstra HJ. Quality of life after hyperthermic isolated limb perfusion for locally advanced extremity soft tissue sarcoma. Ann Surg Oncol. 2006;13:864–71.CrossRefPubMed
Metadaten
Titel
The Patient Experience with Soft Tissue Sarcoma: A Systematic Review of the Literature
verfasst von
Randall Winnette
Lisa M. Hess
Steven J. Nicol
Datchen Fritz Tai
Catherine Copley-Merriman
Publikationsdatum
01.04.2017
Verlag
Springer International Publishing
Erschienen in
The Patient - Patient-Centered Outcomes Research / Ausgabe 2/2017
Print ISSN: 1178-1653
Elektronische ISSN: 1178-1661
DOI
https://doi.org/10.1007/s40271-016-0200-1

Weitere Artikel der Ausgabe 2/2017

The Patient - Patient-Centered Outcomes Research 2/2017 Zur Ausgabe